(Q73094188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

G Ponziani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M L Bartolozzi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Siracusa

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

96-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

An assessment of disability rating scales used in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Clinical and CSF findings in multiple sclerosis patients with or without IgG oligoclonal bands at isoelectric focusing examination of CSF and serum proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Long‐term follow‐up of acute partial transverse myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Clinical and magnetic resonance imaging in optic neuritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900143-4

10.1016/S0022-510X(99)00143-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10526190%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference